SARAJEVO (Bosnia and Herzegovina), September 28 (SeeNews) – Luxembourg-based company Haden acquired 15.34% of Bosnian drug maker Bosnalijek [SAJ:BSNLR], the brokerage house in charge of the transaction said on Friday.